Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CGTX
#3321
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-5.22%
Monatliche Änderung
-18.66%
6 month change
-58.87%
Jahresänderung
+142.22%
Vorheriger Schlusskurs
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Volumen
16
Märkte
Aktien
Gesundheitswesen
CGTX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
22.58 M
29.26 M
39 M
61.97 M
—
Valuation ratios
Enterprise value
87.98 M
18.43 M
45.74 M
18.45 M
119.97 M
Price to earnings ratio
-2.02
-2.25
-2.26
-0.82
-4.89
Price to sales ratio
24.56
1 730.8
2 157.65
-142.89
—
Price to cash flow ratio
9.04
2.61
3.64
0.98
4.62
Price to book ratio
0.64
1.2
2.38
1.49
3.1
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.2
-0.42
-0.73
-1.12
-1.08
Return on equity %
-0.23
-0.53
-1.05
-1.81
-2.2
Return on invested capital %
-7 279.36
-4 738.31
-4 705.93
-7 741.22
—
Gross margin %
100
100
100
100
—
Operating margin %
-2 140.57
-155.54 K
-187.87 K
27.67 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
-876.95
-76.42 K
-95.51 K
17.42 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
7.5
6.11
3.37
2.65
12.73
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0
0
-0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.7
-0.78
-0.53
-0.72
-0.54
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
10.54
1.76
1
0.63
1.65
Net current asset value per share
11.36
2.02
1.14
0.74
2.06
Tangible book value per share
9.88
1.7
0.82
0.47
1.32
Working capital per share
9.85
1.69
0.8
0.46
1.3
Book value per share
9.88
1.7
0.82
0.47
1.32
Nachrichten
Cognition Therapeutics bespricht mit FDA nächste Studienphase für Demenz-Medikament
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition Therapeutics meldet positive Phase-2-Studienergebnisse für DLB-Medikament
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics schließt Patientenrekrutierung für DLB-Studienprogramm ab
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics skizziert Pläne für Phase-3-Studie mit Alzheimer-Wirkstoff
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Alzheimer-Studie: Cognition Therapeutics erreicht Rekrutierungsziel
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?